QYOU Media Hits Monetization With Initial Orders From Leading Brands

Monetization has finally arrived for QYOU Media (TSXV: QYOU). The company this morning announced that it has commenced monetization efforts via early Q1 ad sales for its flagship The Q India channel. The company has seen initial orders from leading national brands that include Britannia, Airtel, SBS Biotech, and Reckitt Benkiser.

After years of working to establish the Q India as a leading channel among youth in India, the company has finally begun to be able to monetize its efforts. The first two weeks of January alone reportedly saw over $200,000 in new add insertions, with additional campaigns expected to launch and scale throughout the quarter.

In addition to achieving significant monetization, the company this morning announced that its BARC ratings continue to improve week over week. The company has seen its average time spent viewing increase to 73 minutes, while its audience has grown to 22 million weekly viewers, giving the company a GRP of 3.9. The company has seen its average viewing time extend to nearly 30 minutes longer than its closest competitor, which is MTV.

“For over three years we have held firm on a three part strategy in India: (1) build the most relevant channel for Young India with content from top social stars and digital creators; (2) secure vast distribution across TV, OTT and mobile platforms while growing a loyal engaged audience and (3) monetize ever increasing viewership via advertising and influencer marketing sales. With the tremendous momentum we have achieved with respect to phases 1 and 2 of the strategy, 2021 marks the beginning of Phase 3 – monetization – we are already seeing the benefits with the onboarding of ads from premium brands.”

Curt Marvis, CEO of QYOU Media

QYOU Media last traded at $0.125 on the TSX Venture.

FULL DISCLOSURE: QYOU Media is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover QYOU Media on The Deep Dive, with The Deep Dive having full editorial control. Additionally, the author personally holds shares of the company. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply